Pharco Pharmaceuticals
Alexandria
6 articles about Pharco Pharmaceuticals
-
The Medicines Patent Pool And Pharco Pharmaceuticals Sign License For Promising Hepatitis C Drug Candidate Ravidasvir
4/21/2017
-
Pharco Pharmaceuticals Reports Ravidasvir Achieved 100% Cure Rate To Date When Combined With Sofosbuvir For HCV, Non-Cirrhotic, Genotype 4 Patients
11/16/2015
-
Pharco Pharmaceuticals Announces Late-Breaker Oral Presentation At American Association for Study of Liver Diseases (AASLD) Liver Meeting 2015
11/4/2015
-
Naia Limited Raises $5.3 Million in Series A Financing Led By Pharco Pharmaceuticals
10/19/2015
-
Pharco Pharmaceuticals Launches The Alexandria Women's Squash Championship - Which Ranks Fifth In Terms Of Points - And Campaigns To Enlist Squash At Tokyo Olympics In 2020
6/10/2015
-
Pharco Pharmaceuticals Licenses Clinical Stage Hepatitis C Virus (HCV) NS5A Inhibitor PPI-668 From Presidio Pharmaceuticals, Inc.
11/10/2014